Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Atlan Clinical
BrandsAtlan Clinical

How AI describes Atlan Clinical

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Atlan Clinical logoAtlan Clinicalatlanclinical.com · Evidence updating

Parse Score

—

#102 of 193 in Clinical Trial Management Software

Work at Atlan Clinical?

Claim this profile for the full report: every prompt where Atlan Clinical appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor Atlan Clinical

Sources

oncodaily.com shapes more of what AI says about Atlan Clinical than any other source, at 100% of its citations.

AI questions where Atlan Clinical appears

Always know where you stand in AI

Start monitoring Atlan Clinical

The market map

Clinical Trial Management Software →
10%20%50%Category leadersSpecialistsIn the mixLong tailNamed in more AI answers →Appears earlier in the answer →MedidataVeevaIQVIAOracleRealTime eClinic…AdvarraCastor EDCSASOCT Clinical Tri…MedableHungaroTrialCrucial Data Sol…Trial InteractiveCloudbyz

Where AI ranks Atlan Clinical

Clinical Trial Management Software#102

  • Excerpts where Atlan Clinical appeared in the AI's answer

    Google AI Mode · excerpt
    Atlan Clinical: Recognized as a leading regional CRO providing expansive clinical trial execution with a strong footprint spanning Eastern Europe
    Google AI Mode · excerpt
    Atlan Clinical operates as a prominent regional provider scaling across Eastern Europe and neighboring areas, recognized for managing complex oncology and hematology portfolios with localized regulatory expertise.